looks like more waiting to do before final result . may be by end of 2015 .
would like to think somewhere soon updates could come out and push the sp along like what has just happened with Novagen
from clinical trial.gov
http://clinicaltrials.gov/ct2/show/NCT01290783?
term=NCT01290783&rank=1This study is ongoing, but not recruiting participants.
Sponsor:
Alchemia Oncology
Information provided by (Responsible Party):
Alchemia Oncology
ClinicalTrials.gov Identifier:
NCT01290783
First received: January 31, 2011
Last updated: February 10, 2013
Last verified: February 2013
Further study details as provided by Alchemia Oncology:
Primary Outcome Measures:
Progression Free Survival (PFS) [ Time Frame: Approximately 20 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
Safety [ Time Frame: After initial 20 patients receive 2 cycles, then 6 monthly thereafter. ] [ Designated as safety issue: Yes ]
Diarrhea and haematology
Estimated Enrollment: 390
Study Start Date: December 2011
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
- Forums
- ASX - By Stock
- TSN
- may be awhile yet
may be awhile yet
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable